Targeting METTL3/m6A/SOCS3 axis reprograms tumor-associated macrophage polarization to potentiate the efficacy of anti-PD-1 therapy in multiple myeloma.
- DOI
- 10.1007/s00018-026-06421-9
- Published
- 2026 Aug 27
- Container
- Cellular and molecular life sciences : CMLS
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1007/s00018-026-06421-9,
title = {Targeting METTL3/m6A/SOCS3 axis reprograms tumor-associated macrophage polarization to potentiate the efficacy of anti-PD-1 therapy in multiple myeloma.},
author = {Wang G and Zhou F and Yan X and Wang J and Yan M and Liu J and Yu L},
year = {2026},
journal = {Cellular and molecular life sciences : CMLS},
doi = {10.1007/s00018-026-06421-9},
url = {https://doi.org/10.1007/s00018-026-06421-9}
}RIS
TY - JOUR TI - Targeting METTL3/m6A/SOCS3 axis reprograms tumor-associated macrophage polarization to potentiate the efficacy of anti-PD-1 therapy in multiple myeloma. AU - Wang G AU - Zhou F AU - Yan X AU - Wang J AU - Yan M AU - Liu J AU - Yu L PY - 2026 JO - Cellular and molecular life sciences : CMLS DO - 10.1007/s00018-026-06421-9 UR - https://doi.org/10.1007/s00018-026-06421-9 ER -
APA
G, W., F, Z., X, Y., J, W., M, Y., J, L., & L, Y. (2026). Targeting METTL3/m6A/SOCS3 axis reprograms tumor-associated macrophage polarization to potentiate the efficacy of anti-PD-1 therapy in multiple myeloma.. Cellular and molecular life sciences : CMLS. https://doi.org/10.1007/s00018-026-06421-9
Source records
- pubmed · retrieved 2026-09-26T02:44:20.190Z